Press Releases

ROSEN, LEADING INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important May 24 Deadline in Securities Class Action – FIXX

NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. (NASDAQ: FIXX) between June 10, 2019 and February 18, 2022, inclusive (the “Class Period”), of the important May 24, 2022 lead plaintiff deadline. SO WHAT: If you purchased […]